“Endocan as a Potential Biomarker for Endothelial Dysfunction in Hypertension: A Study Suggests but Further Research Is Needed”

https://pubmed.ncbi.nlm.nih.gov/38114652

This study suggests that endocan could be a potential biomarker for endothelial dysfunction in hypertension, although further research is needed to confirm its clinical utility.